{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomic Breakthroughs in the Diagnosis and Treatment of Cystic Fibrosis

Activity Steps

Purpose of Activity

To provide information about empirical research into cystic fibrosis (CF) and the impact of new genomic advances on CF diagnosis and treatment.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. recognize recent findings in the study of cystic fibrosis genetics.
  2. identify the implications of these findings for patient teaching and treatment.
Price: $21.95


  • ANCC 2.3 CH
  • DC - BON 2.3 CH
  • FL - BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.

Test Code: AJN0614B
Published: Jun 2014
Expires: 6/4/2021
Required Passing Score: 13/18 (72%)
Authors: Stephanie J. Nakano, BSN, RN; Audrey Tluczek, PhD, RN
Categories: Genetics , Pediatrics
Specialties: Genetics, Pediatrics